Literature DB >> 11309472

Atypical form of dural graft associated Creutzfeldt-Jakob disease: report of a postmortem case with review of the literature.

K Kimura1, A Nonaka, H Tashiro, M Yaginuma, R Shimokawa, R Okeda, M Yamada.   

Abstract

A postmortem case of an atypical form of dural graft associated Creutzfeldt-Jakob disease (CJD) is described. A 42 year old man developed progressive spastic paresis 163 months after a cadaveric dura mater graft. He presented with no myoclonus and very late occurrence of periodic synchronous discharges on EEG. The prion protein (PrP) gene was homozygous for methionine at the polymorphic codon 129. Neuropathological examination disclosed plaque-like PrP deposits with atypical distribution of synaptic PrP accumulations in the brain. This patient represents an atypical form of dural graft associated CJD characterised by unusual clinicopathological features.

Entities:  

Mesh:

Year:  2001        PMID: 11309472      PMCID: PMC1737365          DOI: 10.1136/jnnp.70.5.696

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Disease latency in Creutzfeldt-Jakob disease via dural grafting: a case report.

Authors:  C J Lang; J G Heckmann; V Querner; B Neundörfer; J Kornhuber; M Buchfelder; H A Kretzschmar
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.

Authors:  C A Heath; R A Barker; T F G Esmonde; P Harvey; R Roberts; P Trend; M W Head; C Smith; J E Bell; J W Ironside; R G Will; R S G Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-20       Impact factor: 10.154

3.  Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.

Authors:  C Ishida; S Okino; T Kitamoto; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  Isolated spasticity in sporadic Creutzfeldt-Jakob disease.

Authors:  Milena Marek; Thomas Klockgether; Horst Urbach; Inga Zerr; Hans Kretzschmar; Sebastian Paus
Journal:  J Neurol       Date:  2012-11-16       Impact factor: 4.849

5.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

6.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

Review 7.  Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.

Authors:  Atsushi Kobayashi; Yuichi Matsuura; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Acta Neuropathol Commun       Date:  2014-03-31       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.